Skip to main content

Advertisement

Archived Comments for: The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring

Back to article

  1. NF-kB inhibition

    lawrence Helson, Sign Path Pharma Inc.

    5 January 2012

    This is an interesting study. As a complementary study, it may be worthwhile treating this murine poly-i poly-c model with iv curcumin, another NF-kB inhibitor more commonly available and used by many people.These data strongly suggest, and are a compelling argument against using curcumin in early pregnancy in people.

    Competing interests

    I am CEO of an intravenous curcumin company in Phase 1 trials, rather than a competing interest, certainly helpful in supporting our exclusion criteria section of our current clinical trials.
    www.signpathpharma.com

Advertisement